✦ LIBER ✦

Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial

✍ Scribed by Amadeu Pelegrí; Lourdes Calvo; Antonio Antón; José I. Mayordomo; Jesús Florián; Santiago Vázquez; Angels Arcusa; Marta Martín-Richard; José L. Bayo; Eva Carrasco; Javier Virizuela

Book ID: 115075686
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 107 KB
Volume: 6
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2005.n.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus docetaxel administered

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial

✍ Amadeu Pelegrı́; Lourdes Calvo; José I Mayordomo; Jesús Florián; Santiago Vázque 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Phase II Trial of Gemcitabine/Doxorubici

Phase II Trial of Gemcitabine/Doxorubicin/Paclitaxel Administered Every Other Week in Patients with Metastatic Breast Cancer

✍ Pedro Sánchez-Rovira; Ana Jaén; Encarnación González; Ignacio Porras; Maria Rosa 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB

Capecitabine plus docetaxel every 3 week

Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial

✍ Lorenzen, S; Duyster, J; Lersch, C; von Delius, S; Hennig, M; Bredenkamp, R; Pes 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

Phase II Trial of Weekly Docetaxel/Gemci

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB

Final results of a phase II study of bev

Final results of a phase II study of bevacizumab plus docetaxel for the first-line treatment of metastatic breast cancer (TORI-B01)

✍ S. Hurvitz; H.J. Allen; R.L. Moroose; D. Chan; C. Hagenstad; S.H. Applebaum; G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB